<?xml version="1.0" encoding="UTF-8"?>
<p>8-Substituted-3-(trifluoromethyl)-7,8-dihydroimidazo[2,1-
 <italic>c</italic>][1,2,4]triazin-4(6
 <italic>H</italic>)-ones (
 <bold>I–VIII</bold>, 
 <xref ref-type="fig" rid="F0001">Figure 1</xref>), which structures are supported by their consistent spectroscopic data, were resynthesised for the purposes of current research needs, according to synthetic procedures reported lately. The physico-chemical, structural, pharmacological and pharmacokinetic characterisation of these compounds has been recently published
 <xref rid="CIT0006" ref-type="bibr">
  <sup>6–8</sup>
 </xref>.
</p>
